zepbound and tirzepatide FDA approval for Zepbound: FSU researcher available for context on newly approved weight loss treatment Hold the syringe in place for a few seconds after the injection is complete Tirzepatide Weight Loss Injections &

Zygote 25, 244255

Achievement of normal liver fat content (less than 5%) occurred in 27% of participants receiving 1 mg, 52% receiving 4 mg, 79% receiving 8 mg, and 86% receiving 12 mg at 24 weeks, compared to 0% with placebo

First, the injection refusal conversation changed

Common Feeling dizzy Upset stomach or indigestion Burping Gas (flatulence) Boating Inflamed stomach (gastritis) Reflux or heartburn Gallstones Hair loss Injection site reactions Change in the way food or drink tastes Changed skin sensation Low blood sugar (hypoglycaemia) in patients with diabetes Symptoms of gastritis include: Stomach ache, nausea or vomiting

Even if a peptide seems tolerated in the short term, chronic or repeated use could produce side effects that take months or years to manifest